Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

MHRA warns against herbal remedy black cohosh

Clinical The MHRA has issued a reminder about the risks of herbal remedy black cohosh, which is suspected of causing liver failure in one patient who had to undergo a liver transplant.

The MHRA has issued a reminder about the risks of liver problems with the use of the herbal remedy black cohosh. 

The warning came after the herbal remedy, usually used to treat menopausal symptoms, was suspected of causing liver failure in one patient who had to undergo a liver transplant. An investigation into the case was still ongoing, the MHRA said.

UK medicines watchdog has also received 53 reports of adverse reactions associated with the remedy, which involved abnormal liver function, jaundice and hepatitis.

The MHRA specifically warned against using unlicensed black cohosh products – which are sold legally but are not checked for quality or safety – and said it had recently become aware of some products that did not carry the liver risk warning.

"Unlicensed herbal products may have incomplete, inaccurate or no safety information and can mean you are gambling with your health, especially if you take these products without consulting a GP or qualified healthcare professional," MHRA head of herbal policy Richard Woodfield said.

Authorised products, which are subject to safety monitoring, are registered under the Traditional Herbal Registration scheme and have the THR registration number or logo on the packaging, the MHRA said.

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD015760

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel